| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TNF Pharmaceuticals, Inc. | Interim CFO | Employee Stock Option (Right to Buy) | 25,000 | 17 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000114036125019074-rhodes-ian-2025-05-14 | Renatus Tactical Acquisition Corp I | 14 May 2025 | 0 | $0 | 3 | Chief Financial Officer | 14 May 2025, 21:33 |
| TNFA | TNF Pharmaceuticals, Inc. | 17 Apr 2025 | 1 | $0 | 4 | Interim CFO | 18 Apr 2025, 16:30 |